Tisone, G., Orlando, G., Cardillo, A., Palmieri, G., Manzia, T.m., Baiocchi, L., et al. (2006). Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. JOURNAL OF HEPATOLOGY, 44(4), 702-709 [10.1016/j.jhep.2005.11.047].

Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.

TISONE, GIUSEPPE;PALMIERI, GIAMPIERO;MANZIA, TOMMASO MARIA;BAIOCCHI, LEONARDO;TOTI, LUCA;ANGELICO, MARIO
2006-01-01

Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/18 - Chirurgia Generale
Settore MED/12 - Gastroenterologia
English
Con Impact Factor ISI
HCV-related disease recurrence progresses rapidly after liver transplantation. We hypothesised that withdrawal of immunosuppression might favourably impact on disease progression. METHODS: Weaning off immunosuppression was attempted in 34 HCV-RNA positive patients (mean age 62+/-6.4 years) transplanted 63.5+/-20.1 months earlier, under cyclosporine A monotherapy. Patients were followed for 3 years including yearly protocol liver biopsies. Primary endpoints were feasibility of weaning off immunosuppression and its impact on disease progression. Secondary endpoint was to identify predictors of an immunosuppression-free state and fibrosis progression. RESULTS: Complete and permanent immunosuppression withdrawal was achieved in 8 patients (23.4%), whereas 14 (41.2%) developed rejection within eight months despite an initial response and 12 (35.2%) rejected during tapering. After a mean follow-up 45.5+/-5.8 months weaned patients showed stabilisation/improvement of histological fibrosis (P<0.01), lower necro-inflammation (P<0.02) and improved liver function (P<0.05) compared to weaning-intolerants. Multiple logistic regression identified low blood cyclosporine A trough levels during the first post-transplant week (P=0.004) and initial steroid-free immunosuppression (P<0.008) as independent predictors of sustained weaning. Achievement of immunosoppression freedom (P=0.02) and baseline staging score (P<0.0001) were independently associated with stabilisation/improvement of histological fibrosis. CONCLUSIONS: Reconstitution of immune-competence in the host improves the natural history of HCV recurrence in the graft.
Tisone, G., Orlando, G., Cardillo, A., Palmieri, G., Manzia, T.m., Baiocchi, L., et al. (2006). Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. JOURNAL OF HEPATOLOGY, 44(4), 702-709 [10.1016/j.jhep.2005.11.047].
Tisone, G; Orlando, G; Cardillo, A; Palmieri, G; Manzia, Tm; Baiocchi, L; Lionetti, R; Anselmo, A; Toti, L; Angelico, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons Creative Commons

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/23171
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 141
  • ???jsp.display-item.citation.isi??? 127
social impact